The voice of medical imaging and clinical oncology

NSCLC

PETCT and lung cancer: Selecting those likely to benefit and sparing those with little to gain

Lung cancer is the third commonest cancer in the UK and 75% of patients present with advanced disease (stage III or IV); 10-year survival is only 5%. PETCT is best considered as a tool that aids the selection of those most likely to benefit from potentially curative treatment, either surgical resection or radical radiotherapy, while […]

Dr Peter J G Garmany

Queen Elizabeth University Hospital and West of Scotland Cancer Centre

Read Article

Whole-brain radiotherapy of NSCLC patients with multiple brain metastases – an update

Non-small cell lung cancer (NSCLC) constitutes approximately 85% of all lung cancers, with the majority of patients having advanced disease at presentation. Between 10-20% present with brain metastases (BM) and up to 40% of patients will develop BM. The overall median survival is reported to average three to four months if treated with whole brain […]

Dr Swee-Ling Wong, Dr Ruheena Mendes, Professor Siow Ming Lee

University College London Hospitals NHS Foundation Trust

Read Article

Thoracic 18F-FDG PETCT

Positron emission tomography computed tomography (PETCT) is a hybrid imaging modality that provides both anatomical CT and functional PET information in a single study. In clinical practice the most widely used PET imaging tracer is the glucose analogue labelled positron emitter 18F-Fluorodeoxyglucose (18F-FDG). FDG accumulates in cells that demonstrate increased glucose metabolism typically seen in […]

Dr Allanah Barker, Dr Nagmi Qureshi

Papworth Hospital

Read Article

Stereotactic ablative radiotherapy for lung cancer

Stereotactic ablative radiotherapy (SABR), which is also referred to as stereotactic body radiotherapy (SBRT), is defined as “the precise irradiation of an image defined extra-cranial lesion associated with the use of high radiation dose in a small number of fractions”. SABR is a relatively recent advance in the treatment of small peripheral non-small cell lung […]

Dr Brinda Sethugavalar, Dr Louise Murray, Dr Kevin Franks

Leeds Cancer Centre, St James's University Hospital

Read Article

Percutaneous ablation and the battle against primary lung cancer: A review of current techniques

Lung cancer is the most common type of primary cancer worldwide. In the UK, less than 10% of people diagnosed with lung cancer will survive beyond five years and the disease is responsible for approximately 35,000 deaths per annum. In 2010, 34,859 patients died of lung cancer, 56% men, 44% women, Cancer Research UK. Primary […]

Gemma Marshall, Corey Frazer

Harefield Hospital

Read Article

Advertise: mechel@radmagazine.com

Subscribe: katherine@radmagazine.com

Call: (01371) 812960

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.